Unknown

Dataset Information

0

High-efficiency reprogramming of fibroblasts into cardiomyocytes requires suppression of pro-fibrotic signalling.


ABSTRACT: Direct reprogramming of fibroblasts into cardiomyocytes by forced expression of cardiomyogenic factors, GMT (GATA4, Mef2C, Tbx5) or GHMT (GATA4, Hand2, Mef2C, Tbx5), has recently been demonstrated, suggesting a novel therapeutic strategy for cardiac repair. However, current approaches are inefficient. Here we demonstrate that pro-fibrotic signalling potently antagonizes cardiac reprogramming. Remarkably, inhibition of pro-fibrotic signalling using small molecules that target the transforming growth factor-? or Rho-associated kinase pathways converts embryonic fibroblasts into functional cardiomyocyte-like cells, with the efficiency up to 60%. Conversely, overactivation of these pro-fibrotic signalling networks attenuates cardiac reprogramming. Furthermore, inhibition of pro-fibrotic signalling dramatically enhances the kinetics of cardiac reprogramming, with spontaneously contracting cardiomyocytes emerging in less than 2 weeks, as opposed to 4 weeks with GHMT alone. These findings provide new insights into the molecular mechanisms underlying cardiac conversion of fibroblasts and would enhance efforts to generate cardiomyocytes for clinical applications.

SUBMITTER: Zhao Y 

PROVIDER: S-EPMC4579788 | biostudies-literature | 2015 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

High-efficiency reprogramming of fibroblasts into cardiomyocytes requires suppression of pro-fibrotic signalling.

Zhao Yuanbiao Y   Londono Pilar P   Cao Yingqiong Y   Sharpe Emily J EJ   Proenza Catherine C   O'Rourke Rebecca R   Jones Kenneth L KL   Jeong Mark Y MY   Walker Lori A LA   Buttrick Peter M PM   McKinsey Timothy A TA   Song Kunhua K  

Nature communications 20150910


Direct reprogramming of fibroblasts into cardiomyocytes by forced expression of cardiomyogenic factors, GMT (GATA4, Mef2C, Tbx5) or GHMT (GATA4, Hand2, Mef2C, Tbx5), has recently been demonstrated, suggesting a novel therapeutic strategy for cardiac repair. However, current approaches are inefficient. Here we demonstrate that pro-fibrotic signalling potently antagonizes cardiac reprogramming. Remarkably, inhibition of pro-fibrotic signalling using small molecules that target the transforming gro  ...[more]

Similar Datasets

| S-EPMC6101528 | biostudies-literature
| S-EPMC5821705 | biostudies-literature
| S-EPMC7449812 | biostudies-literature
| S-EPMC3059295 | biostudies-literature
| S-EPMC3369107 | biostudies-literature
| S-EPMC4559819 | biostudies-literature
| S-EPMC2919844 | biostudies-literature
| S-EPMC4288576 | biostudies-literature
2018-02-27 | GSE97265 | GEO
| S-EPMC3390172 | biostudies-literature